Literature DB >> 10048930

Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation.

A E Stewart1, S Dowd, S M Keyse, N Q McDonald.   

Abstract

The crystal structure of the catalytic domain from the MAPK phosphatase Pyst1 (Pyst1-CD) has been determined at 2.35 A. The structure adopts a protein tyrosine phosphatase (PTPase) fold with a shallow active site that displays a distorted geometry in the absence of its substrate with some similarity to the dual-specificity phosphatase cdc25. Functional characterization of Pyst1-CD indicates it is sufficient to dephosphorylate activated ERK2 in vitro. Kinetic analysis of Pyst1 and Pyst1-CD using the substrate p-nitrophenyl phosphate (pNPP) reveals that both molecules undergo catalytic activation in the presence of recombinant inactive ERK2, switching from a low- to high-activity form. Mutation of Asp 262, located 5.5 A distal to the active site, demonstrates it is essential for catalysis in the high-activity ERK2-dependent conformation of Pyst1 but not for the low-activity ERK2-independent form, suggesting that ERK2 induces closure of the Asp 262 loop over the active site, thereby enhancing Pyst1 catalytic efficiency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048930     DOI: 10.1038/5861

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  44 in total

1.  Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19-24, 1999.

Authors:  S Zolnierowicz; M Bollen
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5.

Authors:  Xiao Tao; Liang Tong
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

4.  Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.

Authors:  Margret Mandl; David N Slack; Stephen M Keyse
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 5.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

6.  Arabidopsis MAP kinase phosphatase 1 is phosphorylated and activated by its substrate AtMPK6.

Authors:  Hyeong Cheol Park; Eun Hyeon Song; Xuan Canh Nguyen; Kyunghee Lee; Kyung Eun Kim; Ho Soo Kim; Sang Min Lee; Sun Ho Kim; Dong Won Bae; Dae-Jin Yun; Woo Sik Chung
Journal:  Plant Cell Rep       Date:  2011-04-01       Impact factor: 4.570

Review 7.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

8.  Ligand binding reduces conformational flexibility in the active site of tyrosine phosphatase related to biofilm formation A (TpbA) from Pseudomonasaeruginosa.

Authors:  Dorothy Koveal; Michael W Clarkson; Thomas K Wood; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2013-03-21       Impact factor: 5.469

9.  Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages.

Authors:  Gabriela Molina; Andreas Vogt; Ahmet Bakan; Weixiang Dai; Pierre Queiroz de Oliveira; Wade Znosko; Thomas E Smithgall; Ivet Bahar; John S Lazo; Billy W Day; Michael Tsang
Journal:  Nat Chem Biol       Date:  2009-07-05       Impact factor: 15.040

Review 10.  Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.

Authors:  Ahmet Bakan; John S Lazo; Peter Wipf; Kay M Brummond; Ivet Bahar
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.